XOMA Royalty Corporation (XOMA)
NASDAQ: XOMA · Real-Time Price · USD
25.81
+1.41 (5.78%)
At close: Feb 20, 2026, 4:00 PM EST
25.87
+0.06 (0.23%)
After-hours: Feb 20, 2026, 4:10 PM EST
XOMA Royalty Employees
XOMA Royalty had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$3,623,538
Profits / Employee
$758,154
Market Cap
319.61M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 13 | 0 | - | 13 | 0 |
| Dec 31, 2023 | 13 | 0 | - | 13 | 0 |
| Dec 31, 2022 | 13 | 1 | 8.33% | 12 | 1 |
| Dec 31, 2021 | 12 | 2 | 20.00% | 12 | 0 |
| Dec 31, 2020 | 10 | 0 | - | 10 | 0 |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Sutro Biopharma | 178 |
| Foghorn Therapeutics | 112 |
| Rezolute | 75 |
| Armata Pharmaceuticals | 60 |
| Immuneering | 54 |
| Cybin | 50 |
| ALX Oncology Holdings | 44 |
XOMA News
- 10 days ago - XOMA Royalty: Preferreds Still Offer Compelling Income Despite Call Risk - Seeking Alpha
- 12 days ago - XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc. - GlobeNewsWire
- 5 weeks ago - XOMA Royalty Announces CFO Transition - GlobeNewsWire
- 2 months ago - XOMA Royalty Declares Quarterly Preferred Stock Dividends - GlobeNewsWire
- 2 months ago - XOMA Royalty Announces Closing of Transaction to Acquire Mural Oncology plc - GlobeNewsWire
- 2 months ago - Mural Oncology Announces Sanction of the Scheme by the High Court - GlobeNewsWire
- 3 months ago - XOMA Royalty Announces Closing of Transactions to Acquire LAVA Therapeutics N.V. - GlobeNewsWire
- 3 months ago - XOMA Royalty Reports Third Quarter and Year to Date 2025 Financial Results and Highlights Recent Business Achievements - GlobeNewsWire